Asher Biotherapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
650 Gateway Blvd Ste 100, South San Fran...Phone Number
(650) 416-6789Website
www.asherbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
1
1
1
1
About Asher Biotherapeutics
Asher Biotherapeutics, found in 2019 and based in South San Francisco, is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. The cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types.Explore more
Asher Biotherapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Asher Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Asher Biotherapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Asher Biotherapeutics
Check if Asher Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Asher Biotherapeutics launches new products
Funding: Get notified immidiatlly once Asher Biotherapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Asher Biotherapeutics had a recent Job posting/layoffs
Check out if Asher Biotherapeutics is spiking on competitors!
Asher Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Asher Biotherapeutics
Compare insights from companies similar to Asher Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Asher Biotherapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Asher Biotherapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Asher Biotherapeutics.
Asher Biotherapeutics financials insights
Gather financial insights about Asher Biotherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$55M
Series B
$108M
2024
Series C
$55M
Asher Biotherapeutics Tech Stack
A closer look at the technologies used by Asher Biotherapeutics
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Partnership
Partnership, Research & Development, Intellectual Property, Legal Affairs, Medical Research, Pharmaceuticals
Funding
Funding
Open Position
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Asher Biotherapeutics
Sign Up For FreeTo access detailed company insights
Asher Biotherapeutics, found in 2019 and based in South San Francisco, is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. The cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that... Read More
